Johnson & Johnson is a global leader in the pharmaceutical and medical device industries. Its key products include ...
Ascendis Pharma stock has climbed 24.0% over the past month, yet the current valuation checks and market multiples point to a ...
It is getting acquired by a larger firm in the sector.
From weight-loss pills to cancer drugs, these healthcare giants are investing in pharmaceutical breakthroughs.
The pharma stock is up around 17% this year.
Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.
MarketBeat on MSN
Tarsus Pharmaceuticals enters retina market with iRenix deal, adds IRX-101 to pipeline
Key Points Interested in Tarsus Pharmaceuticals, Inc.? Here are five stocks we like better. Tarsus Pharmaceuticals closed its ...
The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.
A Phase 3 trial failure has erased a year of gains for Ionis Pharmaceuticals in just days, and the ripple effects are ...
ZeroStack Corp. (NASDAQ: ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has secured pharmaceutical distribution purchase ...
A recent study pinpoints the two leading GLP-1 manufacturers as the top pharma companies cited the most across leading AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results